Marianne Vitipon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marianne Vitipon has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Wrona
Łukasiewicz Research Network—Institute of Non-Ferrous Metals, Sowińskiego 5 Street, 44-100 Gliwice, Poland
1 shared publication - Alicja Hryniszyn
Łukasiewicz Research Network—Institute of Non-Ferrous Metals, Sowińskiego 5 Street, 44-100 Gliwice, Poland
1 shared publication - Elisabeth Chartier-Garcia
Chemistry and Biology of Metals, Université Grenoble Alpes, CNRS UMR5249, CEA, IRIG-LCBM, F-38054 Grenoble, France
1 shared publication - Elisabeth Darrouzet
Univ Grenoble Alpes, CEA, CNRS, IRIG, Laboratoire de Chimie et Biologie des Métaux, 17 rue des Martyrs, 38000 Grenoble, France
1 shared publication - Jaana Huotari
VTT Technical Research Centre of Finland, Tekniikantie 21, 02150 Espoo, Finland
1 shared publication - Jacek Mazur
Łukasiewicz Research Network—Institute of Non-Ferrous Metals, Sowińskiego 5 Street, 44-100 Gliwice, Poland
1 shared publication
Latest Publications
- Open Access
- 8 May 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (10) , 576
Metal Oxide Doping Modulates the Performances of Copper Oxide Nanoparticular Biocides
Copper has been used as a biocide for more than one century, in various applications. However, as a biocide, copper, both metallic, as a salt or as copper oxide particles, is toxic not only to its intended targets, mainly bacteria and fungi, but also to all living cells. Because of this toxicity, it is desirable to use forms of copper that maximize the required biocidal activity while minimizing the amount of copper that will be released in the environment. Copper oxide nanoparticles are a good compromise for all these requirements. The high surface ratio allows for good reactivity and thus good biocidal activity, while the small amount of copper present in nanoparticles compared to microparticles allows for a limited environmental release. However, plain copper oxide nanoparticles still show significant cytotoxicity, thereby limiting their use. We, therefore, investigated if doping copper oxide nanoparticles with other metal oxide nanoparticles, namely zinc oxide or titanium dioxide, would alter the functional features of the resulting nanoparticles, hopefully increasing the biocidal activity vs. toxicity balance. We investigated biocidal activity by stringent tests using both Staphylococcus aureus and Escherichia coli as target bacteria. In addition, we investigated toxicity on mammalian macrophages or keratinocytes cell lines, as well as on an insect hemocyte cell line. Doping with zinc oxide decreased the biocidal activity, while increasing toxicity, which was the opposite of our expectations. Doping with titanium dioxide decreased the biocidal activity, but also markedly decreased cytotoxicity, which is an interesting avenue to follow. In addition, we also checked that beyond toxicity, the copper oxide-based nanoparticles did not induce an inflammatory reaction, making them safer to use.
- 8 May 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (10) , 576
Open AccessMetal Oxide Doping Modulates the Performances of Copper Oxide Nanoparticular Biocides
Copper has been used as a biocide for more than one century, in various applications. However, as a biocide, copper, both metallic, as a salt or as copper oxide particles, is toxic not only to its intended targets, mainly bacteria and fungi, but also to all living cells. Because of this toxicity, it is desirable to use forms of copper that maximize the required biocidal activity while minimizing the amount of copper that will be released in the environment. Copper oxide nanoparticles are a good compromise for all these requirements. The high surface ratio allows for good reactivity and thus good biocidal activity, while the small amount of copper present in nanoparticles compared to microparticles allows for a limited environmental release. However, plain copper oxide nanoparticles still show significant cytotoxicity, thereby limiting their use. We, therefore, investigated if doping copper oxide nanoparticles with other metal oxide nanoparticles, namely zinc oxide or titanium dioxide, would alter the functional features of the resulting nanoparticles, hopefully increasing the biocidal activity vs. toxicity balance. We investigated biocidal activity by stringent tests using both Staphylococcus aureus and Escherichia coli as target bacteria. In addition, we investigated toxicity on mammalian macrophages or keratinocytes cell lines, as well as on an insect hemocyte cell line. Doping with zinc oxide decreased the biocidal activity, while increasing toxicity, which was the opposite of our expectations. Doping with titanium dioxide decreased the biocidal activity, but also markedly decreased cytotoxicity, which is an interesting avenue to follow. In addition, we also checked that beyond toxicity, the copper oxide-based nanoparticles did not induce an inflammatory reaction, making them safer to use.